The bottom line is the company has a fda approved product that helps people with a decent share structure we should have some sales and this is way too low of a stock price for what its actually worth
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.